SOT201 for advanced solid tumors
Part of Cancer clinical trials.
This trial tests a new drug called SOT201 for people with advanced solid cancers that have stopped responding to other treatments. It helps the immune system fight the cancer more effectively.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your cancer is advanced or metastatic and has come back after standard treatments
- You have a tumor that can be measured on scans, and you are willing to have a fresh biopsy if it's safe
- You are in fairly good health, able to do daily activities (ECOG 0-1)
- Any side effects from previous treatments have mostly gone away, except hair loss or mild nerve issues
- Your vital organs (heart, liver, kidneys) are working well enough for the trial
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new drug called HS-20105 for people with advanced solid tumors that have stopped responding to standard treatments. It aims to see if the drug can shrink tumors or slow their growth.
This phase 1 study tests an investigational drug called HS-20108 in people with advanced solid tumors. It aims to find a safe dose and see how well the drug works against cancer.
This Phase 1 trial tests HS-20089 in people with advanced solid cancers that have limited standard treatment options. It focuses on safety and early signs of whether the drug can shrink tumors or control them.
This trial tests a new drug called SOT109 for people with advanced colorectal cancer that can't be removed by surgery or has spread. The goal is to see if it is safe, how well it works, and how the body handles it.
This trial tests a new virus-based therapy (OTS-412) that is injected directly into tumors. It is for people with advanced solid tumors that have not responded to other treatments, including immunotherapy.
This trial is testing a new drug called OTP-01 that targets two proteins (PD-1 and VEGFR2) to help your immune system fight cancer and stop tumors from growing. It is for people with advanced solid tumors that have not responded to or cannot have standard treatments.
Hear when a new Advanced Solid Tumor trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.